Kexin Zhang

Kexin Zhang

Auto-generated profile, based on publicly available information

Kexin Zhang

Department of Endocrinology and Metabolism, Shandong Provincial Key Medical and Health Laboratory of Endocrinology and Metabolic Diseases, Affiliated Hospital of Shandong Second Medical University, Weifang, China; Clinical Research Center, Affiliated Hospital of Shandong Second Medical University, Weifang, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
BZBiao Zhang
Biao Zhang
JLJinming Liu
Jinming Liu
YMYuying Mo
Yuying Mo
KZKexin Zhang
Kexin Zhang
BHBingqian Huang
Bingqian Huang
DSDong Shang
Dong Shang
A steady dysfunctional state caused by chronic antigen stimulation in the tumor microenvironment (TME) is known as CD8+ T cell exhaustion. Exhausted-like CD8+ T cells (CD8+ Tex) displayed decreased effector and proliferative capabilities, elevated co-inhibitory receptor generation, decreased cytotoxicity, and changes in metabolism and transcription. TME induces T cell exhaustion through long-term antigen stimulation, upregulation of immune checkpoints, recruitment of immunosuppressive cells, and secretion of immunosuppressive cytokines. CD8+ Tex may be both the reflection of cancer progression and the reason for poor cancer control. The successful outcome of the current cancer immunotherapies, which include immune checkpoint blockade and adoptive cell treatment, depends on CD8+ Tex. In this review, we are interested in the intercellular signaling network of immune cells interacting with CD8+ Tex. These findings provide a unique and detailed perspective, which is helpful in changing this completely unpopular state of hypofunction and intensifying the effect of immunotherapy.

24 March 2022 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
YTYunxu Tian
Yunxu Tian
YZYanbin Zhu
Yanbin Zhu
KZKexin Zhang
Kexin Zhang
MTMiao Tian
Miao Tian
SQShuhui Qin
Shuhui Qin
ZHZhiyong Hou
Zhiyong Hou
Objective: Large sample investigations for risk factors for pneumonia in elderly patients after hip fracture surgeries are lacking. The purpose of this study is to determine the incidence and risk factors for postoperative pneumonia in geriatric patients following hip fracture operations. Methods: A retrospective study of incidence and risk factors in a tertiary referral center between 2016 and 2020 was conducted. Geriatric patients who developed postoperative pneumonia after surgeries of hip fracture during hospitalization stay were defined as cases and those without as controls. Multivariate logistic regression model was used to evaluate risk factors for postoperative pneumonia. Results: This study included 3147 patients, and 182 developed postoperative pneumonia, denoting the rate of 5.8%. In the multivariate analyses, age (OR 1.04; 95% CI 1.02–1.06), sex (males) (OR 2.27; 95% CI 1.64–3.13), respiratory disease (OR 3.74; 95% CI 2.32–6.04), heart disease (OR 1.68; 95% CI 1.14–2.47), cerebrovascular disease (OR 1.58; 95% CI 1.11–2.27), liver disease (OR 2.61; 95% CI 1.33–5.15), preoperative stay (OR 1.08; 95% CI 1.05–1.11) and general anesthesia (OR 1.61; 95% CI 1.15–2.27) were identified as independent risk factors for postoperative pneumonia. Conclusions: This study identified several risk factors for pneumonia in geriatric patients after hip fracture operations, providing a viable preventive strategy for optimizing clinical conditions for reduction of postoperative pneumonia.

19 January 2023 in Annals of Global Health
Verified
Journal Article
Open access
PDF file
CKChengxia Kan
Chengxia Kan
NLNa Liu
Na Liu
KZKexin Zhang
Kexin Zhang
DWDi Wu
Di Wu
YLYunzi Liang
Yunzi Liang
XSXiaodong Sun
Xiaodong Sun
Aims: Pancreatic cancer (PC) is a malignant tumor with a strong invasive nature and low survival rate. We aimed to estimate the PC burden at the global, regional, and national levels in 204 countries from 1990 to 2019. Methods: Detailed data, including the incidence, death, and disability-adjusted life years (DALYs), were analyzed from the Global Burden of Diseases Study 2019. Results: Globally, there were 530,297 (486,175–573,635) incident cases and 531,107 (491,948–566,537) deaths from PC in 2019. The age-standardized incidence rate (ASIR) was 6.6 (6–7.1), and the age-standardized mortality rate (ASMR) was 6.6 (6.1–7.1) per 100,000 person-years. PC caused 11,549,016 (10,777,405–12,338,912) DALYs, with an age-standardized rate of 139.6 (130.2–149.1) per 100,000 person-years. There were increases in estimated annual percentage changes (EAPCs) of ASIR (0.83; 0.78–0.87), ASMR (0.77; 0.73–0.81), and age-standardized DALYs rate (ASDR) (0.67; 0.63–0.71). The global number of incident cases increased by 168.7%, from 197,348 (188,604–203,971) to 530,297 (486,175–573,635); the number of deaths increased by 168.2% from 198,051 (189,329–204,763) to 531,107 (491,948–566,537); and total DALYs increased by 148.5% from 4,647,207 (4,465,440–4,812,129) to 11,549,016 (10,777,405–12,338,912). East Asia and China recorded the highest number of incident cases, deaths, and DALYs. The proportion of deaths was attributable to smoking (21.4%), elevated fasting glucose (9.1%), and high BMI (6%). Conclusions: Our study updated the epidemiological trends and risk factors for PC. PC remains a major hazard to the sustainability of health systems worldwide, with an increasing incidence rate and mortality from 1990 to 2019. More targeted strategies are required to prevent and treat PC.

20 July 2023 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
DJDongqing Jing
Dongqing Jing
XHXiaoli Hou
Xiaoli Hou
XGXiao Guo
Xiao Guo
XZXin Zhao
Xin Zhao
KZKexin Zhang
Kexin Zhang
XSXiaodong Sun
Xiaodong Sun

3 August 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
YSYixin Song
Yixin Song
YMYujie Ma
Yujie Ma
KZKexin Zhang
Kexin Zhang
WZWenqiang Zhang
Wenqiang Zhang
GXGuoji Xiong
Guoji Xiong
XSXiaodong Sun
Xiaodong Sun

1 July 2025 in Genes & Diseases
Verified
Journal Article
Open access
YSYixin Song
Yixin Song
KZKexin Zhang
Kexin Zhang
JZJingwen Zhang
Jingwen Zhang
QLQinying Li
Qinying Li
NHNa Huang
Na Huang
XSXiaodong Sun
Xiaodong Sun
The expression and function of the receptor are controlled by epigenetic changes, such as DNA methylation, histone modification, and noncoding RNAs. These modifications play a pivotal role in receptor activity and can lead to or exacerbate endocrine-related diseases. This review examines the epigenetic alterations of nuclear receptors and their significant impact on conditions such as diabetes, thyroid disorders, and endocrine-related tumors. It highlights current therapies targeting these epigenetic mechanisms, including gene editing, epigenetic drugs, and various other therapeutic approaches. This review offers fresh insight into the mechanisms of endocrine-associated disorders, highlighting the latest progress in the development of novel epigenetic therapies that can be used to address receptor–endocrine interactions.